Federal Supply Schedule 36F79719D0176
Award Date
6/1/19
Last Date to Order
5/31/24
Federal Agency
Veterans Integrated Service Network 12
Awardee
Tetraphase Pharmaceuticals Inc.
Ultimate Awardee
La Jolla Pharmaceutical Company
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract is awarded by the Department of Veterans Affairs (VA) to Paratek Pharmaceuticals, Inc. The contract, identified as 36F79719D0194, is for pharmaceutical and drug products under the FSS-61-IB schedule. The contract has a period of performance from July 15, 2019 to February 1, 2026, with a ceiling value of $225,000.00. The contract is intended to provide the VA with a variety of pharmaceutical and drug products, including those related to hematology. As a...
The provided information details a Federal Supply Schedule (FSS) contract award to Aveo Pharmaceuticals, Inc. by the U.S. Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The $45,580,967.00 ceiling value contract has an ultimate completion date of October 14, 2026. The contract aims to procure pharmaceutical and hematology-related products to support the VA's healthcare operations. As an FSS contract, it allows for the placement of task...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
The Department of Veterans Affairs awarded a Federal Supply Schedule contract to Vyera Pharmaceuticals, LLC to procure drugs, pharmaceuticals, and related hematology products. The potential value of this multiple award schedule is $3.5 million with an ordering period through September 2029. Additionally, the National Acquisition Center established a single award Blanket Purchase Agreement with Vyera Pharmaceuticals on behalf of the Veterans Health Administration. Valued at $450,000, this BPA...
This Federal Supply Schedule contract awards Pacira Pharmaceuticals, Inc. as the prime contractor to provide the Department of Veterans Affairs (VA) with a range of drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The multiple-award, indefinite-delivery/indefinite-quantity (IDIQ) contract has a total potential value of $93,582,250 over the 5-year period of performance from September 2022 to August 2027. As the prime, Pacira Pharmaceuticals will deliver the contracted...
The Department of Veterans Affairs awarded a Federal Supply Schedule (FSS) contract to Hospira Worldwide LLC, a subsidiary of Pfizer Inc., for a wide range of pharmaceutical and medical products under the FSS-61 IB schedule. The $230 million multiple-award contract has a period of performance running from October 1, 2014 through June 30, 2024. Through this FSS contract, Hospira/Pfizer has provided sterile injectable drugs, antibiotics, anesthetics, IV solutions, and other medical supplies to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
This Federal Supply Schedule contract was awarded by the U.S. Department of Veterans Affairs (VA) to Oyster Point Pharma, Inc. The contract, with a ceiling value of $32,900,000.00, is for the delivery of pharmaceutical, drug, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract has a period of performance through April 14, 2027 and was awarded on April 15, 2022. It is a multiple award schedule contract, meaning the VA can place...
Phathom Pharmaceuticals, Inc. has been awarded a Federal Supply Schedule (FSS) contract IDV by the Department of Veterans Affairs (VA) to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract, awarded to the for-profit manufacturer of goods, has a ceiling value of $25,000 and a period of performance from January 2, 2024, to June 30, 2024. This is an interim agreement to enable the VA's Veterans Integrated Service Network 12 to issue task orders...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Vertex Pharmaceuticals Incorporated, a for-profit manufacturer of goods. The contract is for Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract has a potential value of $140,300,000.00 and a period of performance from August 15, 2018 to August...